Scott Isaacs shares that the TRIUMPH-1-OSA and TRIUMPH-2-OSA studies found significant drops in obstructive sleep apnea on retatrutide.
Recap by typeshit. Post by Scott Isaacs on X.
Early uptake of the Wegovy pill outpaced injectable incretin weight loss drugs at a similar stage, HealthDay reported on Oct. 22.
Leftover food can't tell researchers whether someone stopped eating from fullness or from feeling sick, and Medical Xpress explains why that gap matters.
Moss says he once believed GLP-1s caused far more muscle loss than ordinary calorie cutting. He now says he got that wrong.
Topol points to neoantigens, the proteins or peptides on cancer cell surfaces, as the base of personalized cancer therapies.
Goodman got sober in 2007 and says the craving shifted to food. Gupta argues a 2025 trial supports the idea, a link to GLP-1 craving research.
The Democrat & Chronicle lists the affected lot numbers, so anyone using compounded tirzepatide can check their vials.
Loading…